These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28771610)

  • 21. Serum C-reactive protein levels predict survival in hepatocellular carcinoma.
    Nagaoka S; Yoshida T; Akiyoshi J; Akiba J; Torimura T; Adachi H; Kurogi J; Tajiri N; Inoue K; Niizeki T; Koga H; Imaizumi T; Kojiro M; Sata M
    Liver Int; 2007 Oct; 27(8):1091-7. PubMed ID: 17845537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation.
    Cho HJ; Kim JK; Nam JS; Wang HJ; Lee JH; Kim BW; Kim SS; Noh CK; Shin SJ; Lee KM; Cho SW; Cheong JY
    Clin Biochem; 2015 Nov; 48(16-17):1073-8. PubMed ID: 26129878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated plasma fibrinogen levels are associated with a poor prognosis in patients with hepatocellular carcinoma.
    Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M; Tajiri H
    Oncology; 2013; 85(5):269-77. PubMed ID: 24217119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery.
    Zhu CB; Chen LL; Tian JJ; Su L; Wang C; Gai ZT; Du WJ; Ma GL
    Ann Surg Oncol; 2012 Mar; 19(3):817-25. PubMed ID: 21861215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of surgery and radiofrequency ablation on single nodular HCC ⩽5 cm: Cohort study based on serum HCC markers.
    Ueno M; Hayami S; Shigekawa Y; Kawai M; Hirono S; Okada K; Tamai H; Shingaki N; Mori Y; Ichinose M; Yamaue H
    J Hepatol; 2015 Dec; 63(6):1352-9. PubMed ID: 26212030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid function in Rett syndrome.
    Stagi S; Cavalli L; Congiu L; Scusa MF; Ferlini A; Bigoni S; Benincasa A; Rossi B; Pini G
    Horm Res Paediatr; 2015; 83(2):118-25. PubMed ID: 25614013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma.
    An HJ; Jang JW; Bae SH; Choi JY; Yoon SK; Lee MA; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Dec; 18(12):1406-14. PubMed ID: 22821639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pretreatment albumin to globulin ratio, a validated biomarker, predicts prognosis in hepatocellular carcinoma.
    Zhang J; Liu X; Yang Z; Chen Y; Luo R
    J BUON; 2016; 21(4):925-934. PubMed ID: 27685915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal and Euthyroid Ranges of Thyroid Hormones in Serum and Liver Cancer Mortality: A Cohort Study.
    Sohn W; Chang Y; Cho YK; Kim Y; Shin H; Ryu S
    Cancer Epidemiol Biomarkers Prev; 2020 Oct; 29(10):2002-2009. PubMed ID: 32699077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroxine-binding globulin and thyroid hormones after resection of hepatocellular carcinoma.
    Nagasue N; Ohmori H; Hashimoto N; Tachibana M; Kubota H; Uchida M; Yu L
    Am J Gastroenterol; 1997 Jul; 92(7):1187-9. PubMed ID: 9219796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors of spontaneously ruptured hepatocellular carcinoma.
    Han XJ; Su HY; Shao HB; Xu K
    World J Gastroenterol; 2015 Jun; 21(24):7488-94. PubMed ID: 26139994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thyroid hormone changes in women with pre-eclampsia and its relationship with the presence of pre-eclampsia].
    Zhou J; Du J; Ma B; Liu X; Qiu H; Li J; Wang X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Feb; 49(2):109-13. PubMed ID: 24739642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum WFA+ -M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection.
    Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A; Korenaga M; Mizokami M; Narimatsu H
    Liver Int; 2016 Feb; 36(2):293-301. PubMed ID: 26134114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.
    Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A
    J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heredity and lifestyle in the determination of between-subject variation in thyroid hormone levels in euthyroid men.
    Roef G; Taes Y; Toye K; Goemaere S; Fiers T; Verstraete A; Kaufman JM
    Eur J Endocrinol; 2013 Dec; 169(6):835-44. PubMed ID: 24086088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma.
    Zhao YM; Wang L; Dai Z; Wang DD; Hei ZY; Zhang N; Fu XT; Wang XL; Zhang SC; Qin LX; Tang ZY; Zhou J; Fan J
    Int J Cancer; 2011 Nov; 129(10):2463-72. PubMed ID: 21213214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma.
    Sun Y; Zhu S; Wu Z; Huang Y; Liu C; Tang S; Wei L
    Oncotarget; 2017 Apr; 8(14):23427-23435. PubMed ID: 28178643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated serum vitamin B(12) levels in association with tumor markers as the prognostic factors predictive for poor survival in patients with hepatocellular carcinoma.
    Lin CY; Kuo CS; Lu CL; Wu MY; Huang RF
    Nutr Cancer; 2010; 62(2):190-7. PubMed ID: 20099193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.